Beyond three months: Sustained results in clinical trials typically appear with continued use at therapeutic dose
At present, Novo Nordisk has developed injection preparations (Ozempic) and oral preparations (Rybelsus) for semaglutide: Ozempic (semaglutide, injection preparation): is a weekly subcutaneous injection preparation (0.5mg or 1mg), suitable for: (1) as an auxiliary means of diet adjustment and exercise to improve blood sugar control in adult patients with type 2 diabetes (2) It is used for adult patients with type 2 diabetes with cardiovascular disease (CVD) to reduce the risk of major adverse cardiovascular events (MACE, including cardiovascular death, non-fatal heart attack, and non-fatal stroke)
Pricing information is accurate as of April 2026 and may change
The choice between Tirzepatide and Semaglutide depends on individual preferences and health goals, with Tirzepatide offering potential dual benefits in blood sugar control and weight loss
Jaime Almandoz, M.D., M.B.A., Professor of Internal Medicine in the Division of Endocrinology and Medical Director of UTSWs Weight Wellness Program
Burns says, adding that the levels of semaglutide administered in these animal studies were at toxic levels," and not what a person prescribed a weight loss drug would be taking
